» Articles » PMID: 37892811

Effect of Lipids on Diabetic Retinopathy in a Large Cohort of Diabetic Patients After 10 Years of Follow-Up

Abstract

(1) Background: Diabetic retinopathy (DR) remains the leading cause of low vision and blindness in young adults of working age. Although the most important risk factors-such as the duration of diabetes mellitus (DM) and glycemic control measured by HbA1c-are known, the effects of lipids are not as clear. The aim of the present study is to analyze the effects of lipids on the development of DR. (2) Methods: This is a retrospective study of a population of 175,645 DM2 patients, during the period 2010 to 2020, in which the effects of different lipid factors are studied. (3) Results: The variables that most influenced the development of DR in our study, based on significance and cumulative hazard (CH), were arterial hypertension (CH 1.217, < 0.001), HbA1c levels (CH 1.162, = 0.001), microalbuminuria (CH 1.012, < 0.001), LDL-C cholesterol (CH 1.007, = 0.012), TC/HDL-C index (CH 1.092, < 0.001), No-HDL-C/HDL-C index (CH 1.065, = 0.002), the use of statins (CH 1.001, = 0.005), and body mass index (CH 1.007, < 0.001). (4) Conclusions: LDL-cholesterol, TC/HDL-C, and No-HDL-C/HDL-C indices are related to the development of DR, and there is a protective effect of HDL-cholesterol and the use of fibrates.

Citing Articles

Narrative review of comprehensive management strategies for diabetic retinopathy: interdisciplinary approaches and future perspectives.

Pei X, Li Z BMJ Public Health. 2025; 3(1):e001353.

PMID: 40017934 PMC: 11812885. DOI: 10.1136/bmjph-2024-001353.

References
1.
Wilkinson C, Ferris 3rd F, Klein R, Lee P, Agardh C, Davis M . Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003; 110(9):1677-82. DOI: 10.1016/S0161-6420(03)00475-5. View

2.
Natarajan S, Glick H, Criqui M, Horowitz D, Lipsitz S, Kinosian B . Cholesterol measures to identify and treat individuals at risk for coronary heart disease. Am J Prev Med. 2003; 25(1):50-7. DOI: 10.1016/s0749-3797(03)00092-8. View

3.
Kreis A, Wong T, Islam F, Klein R, Klein B, Cotch M . Is nuclear magnetic resonance lipoprotein subclass related to diabetic retinopathy? The multi-ethnic study of atherosclerosis (MESA). Diab Vasc Dis Res. 2009; 6(1):40-2. PMC: 2757060. DOI: 10.3132/dvdr.2009.008. View

4.
Kawasaki R, Kitano S, Sato Y, Yamashita H, Nishimura R, Tajima N . Factors associated with non-proliferative diabetic retinopathy in patients with type 1 and type 2 diabetes: the Japan Diabetes Complication and its Prevention prospective study (JDCP study 4). Diabetol Int. 2019; 10(1):3-11. PMC: 6357241. DOI: 10.1007/s13340-018-0357-z. View

5.
Do D, Han G, Abariga S, Sleilati G, Vedula S, Hawkins B . Blood pressure control for diabetic retinopathy. Cochrane Database Syst Rev. 2023; 3:CD006127. PMC: 10049880. DOI: 10.1002/14651858.CD006127.pub3. View